Stock screenerAll disclosures →
EDGAR →
MGTX
Conviction 98HealthcareScan · Mon, Aug 10, 2026MGTX$13.01-0.46%
ResistanceSupportVol 14Insider sell2
Vol MA14 509.6K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price13.01
Change-0.46%
Gap+0.34%
Rel volume1.91×
Avg volume548.15K
Avg $ vol6.75M
SMA 2012.28
SMA 5011.70
SMA 2009.21
Price vs 50+11.24%
Price vs 200+41.26%
MA stackbullish
50/200 cross—
Supertrenddown · 13.67
RSI (14)60
MACD hist0.05
MACD crossbull · 1d
Stoch %K / %D87 / 92
ADX (14)23
+DI / −DI26 / 14
RSI divergence—
MACD divergence—
ATR %+4.65%
ADR %4.43%
52w high14.66
52w low6.99
From 52w high-11.26%
Above 52w low+86.12%
New 52w highNo
SqueezeOn · 3d
Bollinger width12.88%
%B0.96
Donchian pos86.93%
Donchian high13.27
Donchian low11.28
AVWAP (52w high)12.82
vs AVWAP high+1.47%
AVWAP (52w low)10.49
vs AVWAP low+23.97%
OBV trendFlat
Chaikin MF (20)0.00
Today vs 20d1.91×
Avg vol (14d)509.6K
Avg vol (20d)548.15K
Avg $ vol (20d)6.75M
Market cap1.2B
RS 3m (vs SPY)+29.32%
RS 6m (vs SPY)+67.41%
RS line new highNo
Trend template8/8
Technical rank88.1
1 week+9.51%
1 month-2.84%
3 months+32.48%
6 months+75.10%
1 year+70.73%
YTD+66.58%
P/E-10.55
P/B-20.73
P/S75.68
P/FCF-24.01
EPS-1.42
Div yield—
ROE196.46%
ROA-46.68%
Debt/Eq—
Current0.55
EV/EBITDA-12.13
Gross margin—
Net margin-717.34%
Rev growth-57.77%
EPS growth22.73%
Price target25.00
Target upside92.16%
Analyst ratingBuy
Institutional76.78%
Ent. value1.13B
Revenue5.1M
Net income-46.31M
Gross profit—
Free cash flow-50.19M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out92.61M
Employees409
ListedFri, Jun 8, 2018
Free float55.45M
Float %70.9%
Short interest4.22M
Days to cover3.7d
Short volume56.3%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.57 vs −$0.43
Last surprise-32.6% miss
Setup gradeA+
Conviction98 / 100
Pattern quality—
Tech rank88.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance14.11
Support10.40
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MGTX
No recent disclosed trades by Congress in MGTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MGTX · 6 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Naylor Stuart CHIEF SCI OFCR, OPHTHALMOLOGY · Ordinary Shares · 2026-07-07 | Sell | 2.55K | $35K | 2026-07-07 | 2026-07-07 |
Naylor Stuart CHIEF SCI OFCR, OPHTHALMOLOGY · Ordinary Shares · 2026-07-07 | Sell | 25.11K | $374K | 2026-07-07 | 2026-07-07 |
Naylor Stuart CHIEF SCI OFCR, OPHTHALMOLOGY · Restricted Share Units · 2026-06-25 | Grant | 70K | — | 2026-06-25 | 2026-06-29 |
Giroux Richard CFO & COO · Restricted Share Units · 2026-06-25 | Grant | 980K | — | 2026-06-25 | 2026-06-29 |
Zeldin Robert K CHIEF MEDICAL OFFICER · Restricted Share Units · 2026-06-25 | Grant | 100K | — | 2026-06-25 | 2026-06-29 |
Wollin Robert J GENERAL COUNSEL AND SECRETARY · Restricted Share Units · 2026-06-25 | Grant | 100K | — | 2026-06-25 | 2026-06-29 |
Forbes Alexandria PRESIDENT & CEO · Restricted Share Units · 2026-06-25 | Grant | 980K | — | 2026-06-25 | 2026-06-29 |
Harris Keith R. Director · Restricted Share Units · 2026-06-10 | Exercise | 75K | $0 | 2026-06-10 | 2026-06-10 |
Harris Keith R. Director · Ordinary Shares · 2026-06-10 | Exercise | 75K | — | 2026-06-10 | 2026-06-10 |
Giroux Richard CFO & COO · Ordinary Shares · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-28 |
SEC filings
EDGAR filings in MGTX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.